Amgen stock price
AMGN
#61

346,55 $
  

1.25%

Amgen Info

Capitalización de mercado
186,83B $

1.25%

Volumen diario
217,55M $
Sitio web
Tipo de activo
Acciones
Empleados
28000
Fundado
Apr 8, 1980
Exchange principal
Nasdaq
Industria
Biological Products, (No Diagnostic Substances)
Número CIK
0000318154

Datos de acciones tokenizadas

Prom. del precio tokenizado
347,45 $
Diferencia de precio
+0,8984 $(+0.26%)
Capitalización de mercado tokenizada
49,57K $

1.44%

Volumen tokenizado (24h)
871,32K $

9.84%

Emisores
Contratos
Exploradores
Convertidor de AMGN a USD
AMGN
USD
Rendimiento de precios
Baja
344,52 $
Alta
352,88 $

Cargando datos

Por favor, espera, estamos cargando datos de gráficos

Amgen comunidad

skeleton-white
 
 
 
 
 
 

About Amgen

What is Amgen?

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

Amgen Datos de Precio en vivo

The current price of Amgen in the market is 346,55 $, with a 24-hour trading volume of 217,55M $. The asset's market cap is 186,83B $, after moving -1.25% in the last day.

Tokenized Amgen is trading at 347,45 $, with a tokenized market cap of 49,57K $ and a 24-hour trading volume of 871,32K $. The tokenized asset has moved -1.44% in the past 24 hours.